Express Pharma
Home  »  Pharma Ally  »  ‘Both India and Europe can learn quite a lot from each other based on very long herbal medicinal traditions’

‘Both India and Europe can learn quite a lot from each other based on very long herbal medicinal traditions’


Dr Rainer Kunz, Area Sales Manager, Europe and Middle East, Finzelberg, talks about key features of company’s plant extracts in a discussion with Sachin Jagdale

Which diseases are targeted by your extracts?

20160415ep25Practically all kind of indications are covered by Finzelberg extracts. In focus are cough and cold, digestion, veins, urology, sexuality, CNS (stress, mood, sleep).

Explain the technologies employed to get these extracts.

The following technologies are employed. They are classical technologies like maceration (‘tea – like’ extraction), percolation (‘coffee – like’ extraction) and more modern techniques like counter – current extraction, liquid-liquid extraction or adsorption techniques.

Do you use any ayurvedic plants for extraction? If not, are you planning to do so?

We see candidates from the ayurvedic area for extraction definitively, taking into account the very long Indian tradition on herbals. Our aim is to combine the benefits of the two leading herbal traditions both from India and Europe.

Where do you export these extracts globally?

We export to all continents.

What is your global share in the plant extract market?

Difficult to say. We estimate it to be around 20 per cent.

What are the benefits offered by these extracts?

We offer standardised high quality extracts which go with an excellent documentation, guaranteeing our business partners a maximum of purity and safety (and trustability).

What kind of regulatory support do you provide to your clients?

As a standard, we can offer a basic documentation. It covers the specification of the extract and the method used to standardise the extract. Furthermore, we offer to our customers all-inclusive packages. They include the core documentation for the registration process as a herbal medicinal product (e.g. 3.2.S – part characterising the API and 3.2.P part characterising the part of the finished product in its galenic application, without any question in common CTD-format). On request, we can compile any documentation our clients are asking for.

What makes India the ideal market for you?

India has a very long tradition on herbals. Consequently, we are expecting a high understanding in the population for our concepts in herbal medicines.

India has more than 5000-year-old tradition of ayurvedic medicines. Does it pose a challenge for you?

In fact this poses a high challenge for us, but in a very positive way. We are convinced that both India and Europe can learn quite a lot from each other based on the very long herbal medicinal traditions. Both the long experience in science and usage of herbals but as well the technical know how could be shared. In total, we are convinced that there will be a lot of synergetic effects.

It has to be noted that last year our company celebrated its 140th anniversary. Since then we have been producing plant extracts to the pharmaceutical and health industry.

What targets have been set by you for the Indian market for the next five years?

Our target is to attain the number one position of the non -Indian suppliers of herbal ingredients for the production of health products in India.

[email protected]

Comments are closed.